Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Guaranteeing Quality Medical care with Federal medical care Benefit Plans. - 2Iran's stolen futures: The arrested Iranians at risk of execution by the regime
- 3At UN climate conference, some activists and scientists want more talk on reforming agriculture
- 4FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
- 5Simple Consideration Plants for Home and Office: An Aide
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- Tech for Efficiency: Applications and Apparatuses to Accomplish More
- Volunteers aiding humpback whale stranded in Baltic get death threats
- The 10 Most Famous Style Minutes on Honorary pathway
- UN rights chief says Israeli policy in West Bank 'resembles apartheid system'
- Sahel coups push Africa to top of global democratic declines, report finds
- 10 Natural products to Remember for Your Eating routine for a Better You
- Pick Your Favored kind of soup
- Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
